Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0301 | 0.5893 | 0.5842 |
Leishmania major | dihydrofolate reductase-thymidylate synthase | 0.0478 | 1 | 1 |
Leishmania major | mitochondrial DNA polymerase beta | 0.0301 | 0.5893 | 0.4717 |
Echinococcus granulosus | geminin | 0.0171 | 0.2892 | 0.2892 |
Mycobacterium tuberculosis | Hypothetical protein | 0.0228 | 0.4197 | 0.216 |
Schistosoma mansoni | hypothetical protein | 0.0219 | 0.3995 | 0.3995 |
Trypanosoma brucei | dihydrofolate reductase-thymidylate synthase | 0.0478 | 1 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 0.2892 | 0.2892 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0368 | 0.7433 | 0.6532 |
Chlamydia trachomatis | oxoacyl-ACP synthase III | 0.0368 | 0.7433 | 0.5 |
Echinococcus granulosus | thymidylate synthase | 0.0478 | 1 | 1 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.0035 | 0.5 |
Trypanosoma brucei | RNA helicase, putative | 0.0219 | 0.3995 | 0.2275 |
Loa Loa (eye worm) | thymidylate synthase | 0.0478 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0165 | 0.2746 | 0.2746 |
Echinococcus multilocularis | geminin | 0.0171 | 0.2892 | 0.2892 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0368 | 0.7433 | 0.6532 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta-PAK, putative | 0.0142 | 0.2226 | 0.2128 |
Schistosoma mansoni | aryl hydrocarbon receptor | 0.0049 | 0.0068 | 0.0068 |
Onchocerca volvulus | 0.0478 | 1 | 0.5 | |
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.0035 | 0.5 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.0035 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0165 | 0.2746 | 0.2746 |
Brugia malayi | PAS domain containing protein | 0.0049 | 0.0068 | 0.0068 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0368 | 0.7433 | 0.5 |
Trypanosoma cruzi | mitochondrial DNA polymerase beta, putative | 0.0301 | 0.5893 | 0.5842 |
Plasmodium falciparum | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0478 | 1 | 1 |
Schistosoma mansoni | single-minded | 0.0049 | 0.0068 | 0.0068 |
Trypanosoma brucei | mitochondrial DNA polymerase beta | 0.0301 | 0.5893 | 0.4717 |
Plasmodium vivax | bifunctional dihydrofolate reductase-thymidylate synthase, putative | 0.0478 | 1 | 1 |
Schistosoma mansoni | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0478 | 1 | 1 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0368 | 0.7433 | 0.6532 |
Schistosoma mansoni | hypothetical protein | 0.0171 | 0.2892 | 0.2892 |
Toxoplasma gondii | bifunctional dihydrofolate reductase-thymidylate synthase | 0.0478 | 1 | 1 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase | 0.0478 | 1 | 1 |
Mycobacterium tuberculosis | Probable thymidylate synthase ThyA (ts) (TSASE) | 0.0478 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0228 | 0.4197 | 0.4197 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.0035 | 0.5 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0368 | 0.7433 | 0.6532 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0228 | 0.4197 | 0.5 |
Loa Loa (eye worm) | hypoxia-induced factor 1 | 0.0152 | 0.2451 | 0.2451 |
Trypanosoma cruzi | dihydrofolate reductase-thymidylate synthase, putative | 0.0228 | 0.4197 | 0.4124 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0048 | 0.0035 | 0.5 |
Brugia malayi | hypoxia-induced factor 1 | 0.0152 | 0.2451 | 0.2451 |
Echinococcus multilocularis | thymidylate synthase | 0.0478 | 1 | 1 |
Mycobacterium ulcerans | thymidylate synthase | 0.0478 | 1 | 1 |
Mycobacterium leprae | PROBABLE THYMIDYLATE SYNTHASE THYA (TS) (TSASE) | 0.0478 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 0.25 ug ml-1 | In vitro minimal inhibitory concentration against Escherichia coli ATCC 25922 (Ec(A)) | ChEMBL. | 2104934 |
MIC (functional) | = 0.25 ug ml-1 | In vitro minimal inhibitory concentration against Escherichia coli #311 (Ec(B)) | ChEMBL. | 2104934 |
MIC (functional) | = 0.25 ug ml-1 | In vitro minimal inhibitory concentration against Enterobacter cloacae VGH-84-39 (Et(c)) | ChEMBL. | 2104934 |
MIC (functional) | = 0.25 ug ml-1 | In vitro minimal inhibitory concentration against Staphylococcus aureus Smith (MP) (Sa(A)) | ChEMBL. | 2104934 |
MIC (functional) | = 0.25 ug ml-1 | In vitro minimal inhibitory concentration against Escherichia coli ATCC 25922 (Ec(A)) | ChEMBL. | 2104934 |
MIC (functional) | = 0.25 ug ml-1 | In vitro minimal inhibitory concentration against Escherichia coli #311 (Ec(B)) | ChEMBL. | 2104934 |
MIC (functional) | = 0.5 ug ml-1 | In vitro minimal inhibitory concentration against Staphylococcus aureus ATCC 29213 (Sa(B)) | ChEMBL. | 2104934 |
MIC (functional) | = 1 ug ml-1 | In vitro minimal inhibitory concentration against Morganella morganii CMC-84-39(Mn) | ChEMBL. | 2104934 |
MIC (functional) | = 4 ug ml-1 | In vitro minimal inhibitory concentration Streptococcus faecalis VGH-84 (Sf(V)) | ChEMBL. | 2104934 |
MIC (functional) | = 4 ug ml-1 | In vitro minimal inhibitory concentration against Streptococcus faecalis UCI-85 (Sf(U)) | ChEMBL. | 2104934 |
MIC (functional) | = 8 ug ml-1 | In vitro minimal inhibitory concentration against Pseudomonoas aeruginosa 12-4-4 (Pa) | ChEMBL. | 2104934 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.